CAS: 6945-92-2; Ethyl 2-Hydrazinylacetate Hydrochloride

该化合物是一种化学化合物,其成分是通过乙基乙酯功能组体,与乙酸基酸激素相关联的氢子衍生物,典型的化合物是白色的脱白晶状固体,由于盐盐形式的存在,盐体的溶性比自由基体强,在水中溶性可溶性.该氢子体的存在表明它有潜在的再活性,特别是在凝聚反应中,它可能展示生物活动,从而引起药物研究的兴趣.该盐体表明它是一种盐,可以影响其稳定性和处理特性.与许多氢子衍生物一样,安全防范措施是必要的,因为潜在的毒性和再活性.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号14150-64-2 2-肼基乙酸 | CAS号179474-55-6 2-(2-methanehyd... | CAS号6301-02-6 1-氨基海因 | CAS号30979-39-6 2-(3-甲基-5-氧代-4,... | CAS号623-73-4 重氮乙酸乙酯 | CAS号14150-64-2 2-肼基乙酸 | CAS号63981-22-6 3-(5-nitrofurfu...

合成工艺路线路线简述

    N-Boc-肼乙酸乙酯置于盐酸体系中,用 乙醇,水 作为反应溶剂,以98.4%的收率获得产物肼基乙酸乙酯盐酸盐
    参考文献:一种肼基乙酸乙酯盐酸盐的制备方法
    标题:一种肼基乙酸乙酯盐酸盐的制备方法
    摘要:本发明公开了一种肼基乙酸乙酯盐酸盐的制备方法,属于有机合成技术领域.本发明的技术方案要点为:利用氯乙酸乙酯或溴乙酸乙酯为起始物料,经与肼基甲酸叔丁酯反应上叔丁基保护基,脱保护,成盐酸盐,制得肼基乙酸乙酯盐酸盐.本发明具有反应条件温和,收率高,纯度高,成本低,经济环保和适用于产业化等优点,是一种具有工业生产价值的合成方法.

    海关参考信息

    专利信息


    专利号:US-8178474-B1
    优先权日:1999-04-21
    标题 :Functionalised solid support for alpha-oxoaldehyde synthesis
    发明人:MELNYK OLEG; FRUCHART JEAN-SEBASTIEN; BOUREL LINE; GRAS-MASSE HELENE
    权利人:MELNYK OLEG; FRUCHART JEAN-SEBASTIEN; BOUREL LINE; GRAS-MASSE HELENE; PASTEUR INSTITUT; CENTRE NAT RECH SCIENT
    摘要:The invention relates to a functionalised solid support for the synthesis of compounds comprising at least one α-oxoaldehyde function, to a process for preparing it and to its applications, in particular for the preparation of a library of organic compounds, of a diagnostic reagent, of a microtitration plate and of a biochip, such as a DNA chip. The present invention also relates to a process for the synthesis of organic compounds comprising at least one α-oxoaldehyde function and to the α-oxoaldehyde peptides obtained using this process.

    专利号:FR-2792631-A1
    优先权日:1999-04-21
    标题:Solid supports for the synthesis of compounds having an alpha-oxo-aldehyde group and peptides, made by solid phase synthesis using such supports

    专利号:EP-2436673-A1
    优先权日:2010-09-30
    标 题:Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-beta1-42 peptide
    发明人:ANTIMISIARI SOPHIA; MOURTAS SPIRIDON; NIARAKI ANNA; ZONA CRISTIANO; MASSERINI MASSIMO; NICOTRA FRANCESCO; LA FERLA BARBARA
    权利人:NIARAKI ANNA; UNIV PATRAS; UNIV MILANO BICOCCA; ANTIMISIARI SOFIA; MOURTAS SPIRIDON
    摘要:Amyloid β (Aβ) aggregates are considered as possible targets for therapy and/or diagnosis of Alzheimer disease (AD). It has been previously shown that curcumin targets Aβ plaques and interferes with their formation, suggesting a potential role for prevention or treatment of AD. In the present invention, curcumin-derivatives with improved physicochemical properties were synthesized and a 'click chemistry' as well as a conventional liposome preparation method, were used to generate nanoliposomes decorated with the curcumin derivatives. These derivatives were designed to maintain the planar structure required for interaction with Aβ, as directly confirmed by Surface Plasmon Resonance experiments. Surface Plasmon Resonance experiments, measuring the binding of flowing liposomes to immobilized Aβ1-42, indicated that the liposomes exposing curcumin derivatives have extremely high affinity for Aβ1-42 fibrils (1-5 nM), likely because of the occurrence of multivalent interactions. The present invention describes the synthesis of the curcumin derivatives and the preparation and characterization of new nanoliposomes with a very high affinity for Aβ1-42 fibrils, to be exploited as vectors for the targeted delivery of new diagnostic and therapeutic molecules for AD.

    专利号:US-11312722-B2
    优先权日:2019-05-08
    标 题:Hsp90 inhibitors and uses thereof
    发明人:BROWN LAUREN ELAINE; HUANG DAVID S; COWEN LEAH E; WHITESELL LUKE; MARCYK PAUL
    权利人:UNIV BOSTON; GOVERNING COUNCIL UNIV TORONTO
    摘要:Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related diseases.

    专利号:CN-119954778-A
    优先权日:2025-01-27
    标题 :Synthesis method of lenacipam sodium and series of intermediate compounds thereof

    专利号:CN-110845356-B
    优先权日:2019-11-19
    标 题 :Synthesis method of hydrazino ethyl acetate hydrochloride
    爱斯特(成都)生物制药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.astatech.com.cn
    企业联系电话:028-82666846👤
    📞爱斯特(成都)生物制药股份有限公司 ⚠️参考联系方式
    联系人:余小姐
    电话:028-82666846
    手机:17766791135
    传真:028-82666739
    邮箱:sales@astatech.com.cn
    通信地址: 四川省成都市温江区科林路西段488号
    邮编: 611137
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:四川省成都市温江区科林路西段488号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏贵仁医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guirenchem.com
    企业联系电话:0519-83489086;13601507568👤
    📞江苏贵仁医药有限公司 ⚠️参考联系方式
    联系人:任经理qq:2402623097
    电话:0519-83489086;13601507568
    手机:13601507568
    传真:qq:2402623097
    邮箱:guiren_medicine@163.com
    通信地址: 江苏省常州市芮城县风陵渡开发区振兴北街北侧
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Curcumin Derivatives With Improved Physicochemical Properties And Nanoliposomes Surface-Decorated With The Derivatives With Very High Affinity For Amyloid-Beta1-42 Peptide
    摘要:Amyloid β (Aβ) Aggregates Are Considered As Possible Targets For Therapy And/or Diagnosis Of Alzheimer Disease (Ad). It Has Been Previously Shown That Curcumin Targets Aβ Plaques And Interferes With Their Formation, Suggesting A Potential Role For Prevention Or Treatment Of Ad. In The Present Invention, Curcumin-Derivatives With Improved Physicochemical Properties Were Synthesized And A "Click Chemistry" As Well As A Conventional Liposome Preparation Method, Were Used To Generate Nanoliposomes Decorated With The Curcumin Derivatives. These Derivatives Were Designed To Maintain The Planar Structure Required For Interaction With Aβ, As Directly Confirmed By Surface Plasmon Resonance Experiments. Surface Plasmon Resonance Experiments, Measuring The Binding Of Flowing Liposomes To Immobilized Aβ1-42, Indicated That The Liposomes Exposing Curcumin Derivatives Have Extremely High Affinity For Aβ1-42 Fibrils (1-5 Nm), Likely Because Of The Occurrence Of Multivalent Interactions. The Present Invention Describes The Synthesis Of The Curcumin Derivatives And The Preparation And Characterization Of New Nanoliposomes With A Very High Affinity For Aβ1-42 Fibrils, To Be Exploited As Vectors For The Targeted Delivery Of New Diagnostic And Therapeutic Molecules For Ad.

    合成参考文献


    参考文献:10.1007/978-3-662-65895-6_343
    摘要:Pardasani RT, Pardasani P. Magnetic properties of copper(II) complex of N-heteroaromatic hydrazone. 2023. In: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 7.
    参考文献:10.1007/978-3-662-65895-6_344
    摘要:Pardasani RT, Pardasani P. Magnetic properties of copper(II) complex of N-heteroaromatic hydrazone. 2023. In: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 7.
    参考文献:10.1007/978-3-662-65895-6_429
    摘要:Pardasani RT, Pardasani P. Magnetic properties of binuclear copper(II) complex of N-heteroaromatic hydrazone. 2023. In: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 7.
    参考文献:10.1007/s42250-025-01270-8
    摘要:Ben Jaballah O, Ferchichi I, Azzouni S, Horchani M, Ben Jannet H, Arfaoui Y, Efrit ML. Exploring the Synthesis of Trisubstituted 1,2,4-Triazoles from Functionalized Imidates: Experimental and Theoretical Approaches. Chemistry Africa. 2025 Apr 25;8(5):1869–87. doi: 10.1007/s42250-025-01270-8.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知